Skip to main content

Table 3 The mean orthoptic measurements at each follow-up points

From: A randomized trial evaluating efficacy of overminus lenses combined with prism in the children with intermittent exotropia

 

Overminus and prism

Observation

p value

Refractive error (SE, D)

 pretreatment

1.59 ± 1.05

1.64 ± 1.29

0.254

 1 month

1.59 ± 1.05#

1.64 ± 1.29##

0.254

 3 months

1.34 ± 1.08#

1.54 ± 1.29##

0.342

 6 months

1.34 ± 1.08#

1.48 ± 1.25##

0.271

 12 months

1.43 ± 1.12#

1.42 ± 1.25##

0.353

Exotropia control

 pretreatment

5.37 ± 1.65

5.60 ± 1.50

0.569

 1 month

3.70 ± 1.26*

5.50 ± 1.43##

< 0.01

 3 months

2.38 ± 0.98*

5.67 ± 1.30##

< 0.01

 6 months

2.17 ± 1.00*

5.76 ± 1.28##

< 0.01

 12 months

1.75 ± 1.18*

5.72 ± 1.28##

< 0.01

Exodeviation by PACT at distance (PD)

 pretreatment

27.80 ± 7.48

27.46 ± 7.60

0.865

 1 month

22.80 ± 7.50*

27.80 ± 8.14##

0.017

 3 months

22.72 ± 7.62*

28.03 ± 8.16##

0.012

 6 months

22.55 ± 7.62*

28.83 ± 8.23##

0.004

 12 months

22.46 ± 7.61*

27.48 ± 7.24##

0.014

Exodeviation by PACT at near (PD)

 pretreatment

25.13 ± 6.84

26.46 ± 8.08

0.493

 1 month

16.93 ± 7.09*

26.76 ± 8.19##

< 0.01

 3 months

16.37 ± 6.11*

27.00 ± 8.20##

< 0.01

 6 months

16.13 ± 5.87*

26.66 ± 7.63##

< 0.01

 12 months

16.25 ± 7.03*

26.72 ± 7.41##

< 0.01

Preschool Randot near stereoacuity, arcsec (log arcsec)

 pretreatment

2.14 ± 0.46

2.19 ± 0.44

0.717

 1 month

1.97 ± 0.33*

2.19 ± 0.44##

0.03

 3 months

1.96 ± 0.29*

2.19 ± 0.44##

0.021

 6 months

1.95 ± 0.28*

2.17 ± 0.42##

0.017

 12 months

1 .91 ± 0.26*

2.16 ± 0.42##

0.01

  1. *Compared with pretreatment in treatment group, p<0.05; #Compared with pretreatment in treatment group, p>0.05; ##Compared with pretreatment in observation groups, p>0.05